Daily Dispatch is the publisher behind a portfolio of trusted independent news services covering Australia and New Zealand's healthcare, life sciences, and biopharmaceutical sectors.
Our flagship platform, BioPharmaDispatch, delivers breaking news, commentary and in-depth analysis focused on the policy, funding, regulatory and commercial issues shaping the biopharmaceutical and life sciences industries. Founded in 2012, BioPharmaDispatch has become a valued and influential voice across government, industry, and the broader health policy community.
With a sharp focus on the intersection of politics, process, and health innovation, BioPharmaDispatch provides readers with a perspective often missing from traditional coverage. Regular commentary and analysis from founder and publisher Paul Cross further distinguish the service for its informed, insider insight.
In addition to BioPharmaDispatch, Daily Dispatch publishes BiotechDispatch, focused on the biotechnology sector.
We are also the producers of The Dispatched Podcast — a series of frank, policy-focused conversations exploring the ideas, decisions, and people shaping Australia’s health and life sciences sectors. The podcast features interviews with industry leaders, policymakers and stakeholders, offering listeners timely insights beyond the headlines.
We remain committed to independent journalism that informs, challenges, and supports a more transparent conversation across the sectors we serve.
